{"nct_id": "NCT05830929", "age": "Adults", "cancer_center_accrual_goal_upper": 0, "data_table4": "Interventional", "drug_list": {"drug": [{"drug_name": "Procedure: Ovarian tissue freezing and subsequent auto-transplantation after thawing"}]}, "long_title": "Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients", "management_group_list": {"management_group": [{"is_primary": "Y", "management_group_name": "Group1"}]}, "oncology_group_list": {"oncology_group": [{"group_name": "Group1", "is_primary": "N"}]}, "phase": "NA", "principal_investigator": "", "principal_investigator_institution": "Chinese University of Hong Kong", "program_area_list": {"program_area": [{"is_primary": "Y", "program_area_name": "Program1"}]}, "protocol_id": 0, "protocol_no": "", "protocol_target_accrual": 100, "protocol_type": "INTERVENTIONAL", "prior_treatment_requirements": ["Inclusion Criteria:", "* Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients", "* Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;", "* Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future.", "Exclude - Exclusion Criteria:", "Exclude - * Patients with no anticipated oncologic therapies", "Exclude - * Patients who are pregnant", "Exclude - * Children with one ovary", "Exclude - * Children deemed high risk for perioperative complications", "Exclude - * Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)"], "short_title": "Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients", "site_list": {"site": []}, "sponsor_list": {"sponsor": [{"is_principal_sponsor": "Y", "sponsor_name": "Chinese University of Hong Kong", "sponsor_protocol_no": "", "sponsor_roles": "sponsor"}]}, "staff_list": {"protocol_staff": []}, "status": "open to accrual", "summary": "Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.", "treatment_list": {"step": [{"arm": [{"arm_code": "Ovarian tissue freezing and subsequent auto-transplantation after thawing", "arm_internal_id": 0, "arm_description": "Ovarian tissue freezing and subsequent auto-transplantation after thawing", "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Procedure: Ovarian tissue freezing and subsequent auto-transplantation after thawing", "level_internal_id": 0, "level_suspended": "N"}]}], "match": [{"and": [{"clinical": {"oncotree_primary_diagnosis": "", "disease_status": ["", ""]}}, {"genomic": {"hugo_symbol": "", "variant_category": ""}}]}]}]}}